科研製薬【4521】 利益剰余金の推移

機能の使い方
(単位:百万円) 利益剰余金 前年比(%)
3Q26 124,879 -11.1%
2Q26 128,090 -8.5%
1Q26 127,368 -0.0%
4Q25 135,242 +5.2%
3Q25 140,472 +10.5%
2Q25 139,949 +9.9%
1Q25 127,418 +1.3%
4Q24 128,506 +1.9%
3Q24 127,155 -2.1%
2Q24 127,390 -1.6%
1Q24 125,832 -0.5%
4Q23 126,135 -0.2%
3Q23 129,844 +2.2%
2Q23 129,472 +2.5%
1Q23 126,416 +2.8%
4Q22 126,347 +3.2%
3Q22 127,044 +5.9%
2Q22 126,359 +6.0%
1Q22 123,000 +6.2%
4Q21 122,462 +6.6%
3Q21 119,991 +8.1%
2Q21 119,174 +10.5%
1Q21 115,768 +12.2%
4Q20 114,869 +5.3%
3Q20 110,966 +5.2%
2Q20 107,877 +4.6%
1Q20 103,156 +4.9%
4Q19 109,057 +12.1%
3Q19 105,529 +11.0%
2Q19 103,101 +11.9%
1Q19 98,296 +13.3%
4Q18 97,284 +15.4%
3Q18 95,100 +18.4%
2Q18 92,134 +19.9%
1Q18 86,729 +21.9%
4Q17 84,331 +22.9%
3Q17 80,297 +18.8%
2Q17 76,826 +22.4%
1Q17 71,176 +25.8%
4Q16 68,609 +29.6%
3Q16 67,599 -
2Q16 62,765 -
1Q16 56,581 -
4Q15 52,932 -